Teva: New Generic Launches Will Benefit Earnings (NYSE:TEVA) | Seeking Alpha
Form 6-K TEVA PHARMACEUTICAL INDU For: Sep 09
SEC Filing Fee Exhibit, Payment and Related Changes | Goodwin - JDSupra
Teva Investor Relations by Teva Pharmaceuticals USA, Inc.
SEC Filing Fee Exhibit, Payment and Related Changes | Goodwin - JDSupra
Is Teva Pharmaceutical Industries Limited (NYSE:TEVA) Popular Amongst Institutions?
Teva Investor Relations by Teva Pharmaceuticals USA, Inc.
DEF 14A
Stock Forecast Based On a Predictive Algorithm | I Know First |Stock Forecast: Teva Shares Rally After Buffet Announces His Doubled Position in Teva Stock
Teva won't say whether R&D cuts include layoffs; Cipla inks deal for Iranian plant; | Fierce Pharma
SEC Filing | Adamis Pharmaceuticals Corporation
Teva China API plant smacked by FDA warning letter, adding to drugmaker's burdens
Form 10-K
As U.S. Domestic Issuer, Teva Reveals Top Stock Owners | Ctech
Teva confirms US FDA warning letter for Hangzhou, China API plant